Awake vs. Sedated Cannulation for Extra-Corporeal Membrane Oxygenation in Patients with COVID-19 Induced Acute Respiratory Distress Syndrome

<b>Background:</b> Veno-venous extra-corporeal membrane oxygenation (ECMO) cannulations are mostly performed while patients are heavily sedated and mechanically ventilated. For patients with acute respiratory distress syndrome (ARDS), cannulating for ECMO while awake and spontaneously breathing, as well as treating without sedation and mechanical ventilation, has potential advantages. This study aimed to compare clinical outcomes between patients cannulated for ECMO while awake and patients cannulated while sedated and mechanically ventilated. <b>Methods:</b> A retrospective multicenter study. Data were accessed from the Israeli ECMO registry of patients with COVID-19-induced ARDS treated at eight ECMO centers in Israel. The study group comprised 24 patients who were cannulated while awake and spontaneously breathing. A control group comprised 96 patients who were cannulated after sedation and mechanical ventilation, matched 1:4 by age, sex, and body mass index. The primary outcome was six-month survival. Secondary outcomes were: the duration of ECMO therapy, the duration of invasive mechanical ventilation-free ECMO therapy, and the duration of invasive mechanical ventilation. <b>Results</b>: The mean age was 52 + 11 years; 78% were males. Fifteen patients (63%) in the study group were eventually intubated. The mean durations on ECMO and in the intensive care unit did not differ between the groups. The study group had a higher six-month survival (75% vs. 49%, <i>p</i> = 0.02) and fewer infectious complications such as pneumonia or bacteremia (21% vs. 40%, <i>p</i> < 0.001) compared to the control group. After adjusting for PO<sub>2</sub>/FiO<sub>2</sub> ratio and for the COVID-19 variant, the hazard ratio was 0.45 (C.I 0.19-1.06, <i>p</i> = 0.069). <b>Conclusions</b>: Awake VV-ECMO cannulation in COVID-19-induced ARDS is feasible in selected patients and was associated with higher survival in unadjusted analyses. However, after adjustment for key covariates, this association was attenuated and did not reach statistical significance.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-01-21
DOI
https://doi.org/10.3390/jcm15020876
Primary Topic
Mechanical Circulatory Support Devices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Awake vs. Sedated Cannulation for Extra-Corporeal Membrane Oxygenation in Patients with COVID-19 Induced Acute Respiratory Distress Syndrome

Ori Galante, Anton Bukhin, Eduard Ilgiyaev, A. Soroksky et al.
Journal of Clinical Medicine
Mechanical Circulatory Support Devices
article

Awake vs. Sedated Cannulation for Extra-Corporeal Membrane Oxygenation in Patients with COVID-19 Induced Acute Respiratory Distress Syndrome

Ori Galante, Anton Bukhin, Eduard Ilgiyaev, A. Soroksky, Meital Zikri-Ditch, Nitzan Sagie, Yigal Kasiff, Yael Haviv, Dekel Stavi, Daniel Fink
article en

Abstract

<b>Background:</b> Veno-venous extra-corporeal membrane oxygenation (ECMO) cannulations are mostly performed while patients are heavily sedated and mechanically ventilated. For patients with acute respiratory distress syndrome (ARDS), cannulating for ECMO while awake and spontaneously breathing, as well as treating without sedation and mechanical ventilation, has potential advantages. This study aimed to compare clinical outcomes between patients cannulated for ECMO while awake and patients cannulated while sedated and mechanically ventilated. <b>Methods:</b> A retrospective multicenter study. Data were accessed from the Israeli ECMO registry of patients with COVID-19-induced ARDS treated at eight ECMO centers in Israel. The study group comprised 24 patients who were cannulated while awake and spontaneously breathing. A control group comprised 96 patients who were cannulated after sedation and mechanical ventilation, matched 1:4 by age, sex, and body mass index. The primary outcome was six-month survival. Secondary outcomes were: the duration of ECMO therapy, the duration of invasive mechanical ventilation-free ECMO therapy, and the duration of invasive mechanical ventilation. <b>Results</b>: The mean age was 52 + 11 years; 78% were males. Fifteen patients (63%) in the study group were eventually intubated. The mean durations on ECMO and in the intensive care unit did not differ between the groups. The study group had a higher six-month survival (75% vs. 49%, <i>p</i> = 0.02) and fewer infectious complications such as pneumonia or bacteremia (21% vs. 40%, <i>p</i> < 0.001) compared to the control group. After adjusting for PO<sub>2</sub>/FiO<sub>2</sub> ratio and for the COVID-19 variant, the hazard ratio was 0.45 (C.I 0.19-1.06, <i>p</i> = 0.069). <b>Conclusions</b>: Awake VV-ECMO cannulation in COVID-19-induced ARDS is feasible in selected patients and was associated with higher survival in unadjusted analyses. However, after adjustment for key covariates, this association was attenuated and did not reach statistical significance.

Journal of Clinical MedicineVol. 15(2)
Ben-Gurion University of the Negev (IL), Tel Aviv University (IL), Hebrew University of Jerusalem (IL), Tel Aviv Sourasky Medical Center (IL), Sheba Medical Center (IL), Kaplan Medical Center (IL), Wolfson Medical Center (IL), Rambam Health Care Campus (IL), Shaare Zedek Medical Center (IL)
Good health and well-being
Openalex Percentile: Top 82%
Mechanical Circulatory Support Devices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.